Prestige Consumer Healthcare (PBH) Profit After Tax (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Profit After Tax came in at $1.4 million in Q4 2025, down 97.76% year-on-year from $61.0 million in Q4 2024, and down 96.81% quarter-over-quarter from $42.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Profit After Tax (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Profit After Tax history runs 16 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- On a quarterly basis, Profit After Tax fell 97.76% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $96.6 million, a 55.24% decrease from a year earlier, with the FY2025 full-year figure at $211.4 million, up 2.44% from the prior year.
- Profit After Tax fell to $1.4 million in Q4 2025 per PBH's latest filing, from $42.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at $162.1 million in Q1 2021 and bottomed at -$7.1 million in Q3 2022.
- The 5-year median for Profit After Tax is $46.7 million (2024), against an average of $36.4 million.
- Across the five-year window, Profit After Tax slumped 178.43% in 2021 and surged 5786.42% in 2022, its largest moves.
- Year by year, Profit After Tax stood at $50.2 million in 2021, then increased by 3.46% to $52.0 million in 2022, then slumped by 85.63% to $7.5 million in 2023, then jumped by 717.58% to $61.0 million in 2024, then slumped by 97.76% to $1.4 million in 2025.
- Per Business Quant, the three latest PBH Profit After Tax figures stand at $1.4 million (Q4 2025), $42.9 million (Q3 2025), and $5.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.41 Bn | 2.35 Bn | 157.37 Mn | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 42.87 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Mar 31, 2025 | 46.96 Mn |
| Dec 31, 2024 | 61.03 Mn |
| Sep 30, 2024 | 59.18 Mn |
| Jun 30, 2024 | 49.07 Mn |
| Mar 31, 2024 | 46.53 Mn |
| Dec 31, 2023 | 7.47 Mn |
| Sep 30, 2023 | -3.78 Mn |
| Jun 30, 2023 | 52.63 Mn |
| Mar 31, 2023 | -2.08 Mn |
| Dec 31, 2022 | 51.95 Mn |
| Sep 30, 2022 | -7.12 Mn |
| Jun 30, 2022 | 55.27 Mn |
| Mar 31, 2022 | 52.86 Mn |
| Dec 31, 2021 | 50.22 Mn |
| Sep 30, 2021 | -3.65 Mn |
| Jun 30, 2021 | -972,000.00 |
| Mar 31, 2021 | 162.11 Mn |